Citations

Clear

3942 citation(s) found for "To, Van".

Out-of-Pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients
Sharma, Vidit , Jiang, David H. , Houten, Holly K. Van , Sangaralingham, Lindsey R. , Kwon, Eugene D., Dusetzina, Stacie B. , Tilburt, Jon C. , Boorjian, Stephen A. , Joyce, Daniel D , Borah, Bijan J. , Dusetzina, Stacie , Joyce, Daniel , Penson, David F.

Mayo Clinic

Journal of Urology | September 12, 2022 | Volume: 208 | Issue: 5 | Pages: 987-996

10.1097/ju.0000000000002856 | PMID 36094864 Get It

Sinus Tachycardia: a Multidisciplinary Expert Focused Review
Mayuga, Kenneth A. , Fedorowski, Artur , Ricci, Fabrizio , Gopinathannair, Rakesh , Dukes, Jonathan W., Hanna, Peter , Sorajja, Dan , Chung, Mina K. , Benditt, David G. , Sheldon, Robert S. , Ayache, Mirna , AbouAssi, Hiba, Shivkumar, Kalyanam , Hamdan, Mohamed H. , Stavrakis, Stavros , Singh, Tamanna , Muldowney, James A.S. , Belham, Mark , Kem, David C. , Bruce, Barbara K. , Zahka, Nicole E. , Fu, Qi , Iterson, Erik H. Van , Fouad-Tarazi, Fetnat M., Stewart, Julian M. , Hanna, Peter , Sorajja, Dan , Chung, Mina , Benditt, David , Sheldon, Robert , Shivkumar, Kalyanam , Stavrakis, Stavros , Singh, Tamanna , Goldberger, Jeffrey J , Muldowney, James A S , Belham, Mark , Kem, David C , Akin, Cem , Bruce, Barbara K , Zahka, Nicole E , Fu, Qi , Van Iterson, Erik H , Raj, Satish R , Stewart, Julian , Olshansky, Brian , Fedorowski, Artur , Gopinathannair, Rakesh , Ricci, Fabrizio , Gibbons, Christopher H. , Grubb, Blair P. , Akin, Cem , Goldstein, David S. , Olshansky, Brian

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | September 8, 2022 | Volume: 15 | Issue: 9 | Pages: No page available

10.1161/circep.121.007960 | PMID 36074973 Get It

Sinus tachycardia (ST) is ubiquitous, but its presence outside of normal physiological triggers in otherwise healthy individuals remains a commonly encountered phenomenon in medical practice. In many cases, ST can be readily explained by a current medical condition that precipitates an increase in the sinus rate, but ST at rest without physiological triggers may also represent a spectrum of normal. In other cases, ST may not have an easily explainable cause but may represent serious underlying pathology and can be associated with intolerable symptoms. The classification of ST, consideration of possible etiologies, as well as the decisions of when and how to intervene can be difficult. ST can be classified as secondary to a specific, usually treatable, medical condition (eg, pulmonary embolism, anemia, infection, or hyperthyroidism) or be related to several incompletely defined conditions (eg, inappropriate ST, postural tachycardia syndrome, mast cell disorder, or post-COVID syndrome). While cardiologists and cardiac electrophysiologists often evaluate patients with symptoms associated with persistent or paroxysmal ST, an optimal approach remains uncertain. Due to the many possible conditions associated with ST, and an overlap in medical specialists who see these patients, the inclusion of experts in different fields is essential for a more comprehensive understanding. This article is unique in that it was composed by international experts in Neurology, Psychology, Autonomic Medicine, Allergy and Immunology, Exercise Physiology, Pulmonology and Critical Care Medicine, Endocrinology, Cardiology, and Cardiac Electrophysiology in the hope that it will facilitate a more complete understanding and thereby result in the better care of patients with ST.
Substrate Characterization and Outcomes of Catheter Ablation of Ventricular Arrhythmias in Patients With Mitral Annular Disjunction
Ezzeddine, Fatima M. , Siontis, Konstantinos C. , Giudicessi, John R. , Ackerman, Michael J. , Killu, Ammar M. , Deshmukh, Abhishek , Madhavan, Malini , Zyl, Martin van , Vaidya, Vaibhav R. , Karki, Roshan , Munger, Thomas M. , Asirvatham, Samuel J. , Munoz, Freddy Del‐Carpio , Giudicessi, J R , Deshmukh, Abhishek J , van Zyl, Martin , Tseng, A S , McLeod, Christopher J , Asirvatham, Samuel J , Del-Carpio Munoz, Freddy , Ezzeddine, Fatima , Tseng, Andrew S. , McLeod, Christopher J.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | September 8, 2022 | Volume: 15 | Issue: 9 | Pages: No page available

10.1161/circep.122.011088 | PMID 36074649 Get It

Background: Mitral annular disjunction (MAD) has recently been recognized as an arrhythmogenic entity. Data on the electrophysiological substrate as well as the outcomes of catheter ablation of ventricular arrhythmias in patients with MAD is limited. Methods: Forty patients with MAD (mean age 47±15 years; 70% female) underwent catheter ablation for ventricular arrhythmias. Detailed clinical, electrocardiographic, cardiac imaging, and procedural data were collected. Clinical outcomes were compared between patients who had substrate modification in the MAD area and those who did not. Results: Twenty-three (57.5%) patients had ablation for premature ventricular contractions, 10 (25%) patients for sustained ventricular tachycardia, and 7 (17.5%) patients for premature ventricular contraction-triggered ventricular fibrillation. Mean end-systolic MAD length was 10.58±3.49 mm on transthoracic echocardiography. Seventeen (42.5%) patients had preprocedural cardiac magnetic resonance imaging, and 5 (29%) patients had late gadolinium enhancement. Among the 18 (45%) patients who had abnormal local electrograms (low voltage, long-duration, fractionated, isolated mid-diastolic potentials) during electroanatomical mapping, 10 (25%) patients had abnormal electrograms in the anterolateral mitral annulus and/or MAD area. Substrate modification was performed in 10 (25%) patients. Catheter ablation was acutely successful in 36 (90%) patients (elimination of premature ventricular contraction or noninducibility of ventricular tachycardia). After a median follow-up duration of 54.08 (interquartile range, 10.67–89.79) months, premature ventricular contraction burden decreased from a median of 9.75% (interquartile range, 3.25–14) before the ablation to a median of 4% (interquartile range, 1–7.75) after the ablation ( P =0.03 [95% CI, 0.055–6.5]). Eight (20.5%) patients had repeat ablation for ventricular arrhythmias. Substrate modification of the MAD was associated with a trend toward lower rates of repeat ablation (0% versus 26.7%; P =0.16). Conclusions: Patients with MAD have a complex arrhythmogenic substrate, and catheter ablation is effective in reducing recurrence of ventricular arrhythmias. Substrate mapping and ablation may be considered in these patients.
International Consensus Statement on Obstructive Sleep Apnea
Chang, Jolie L. , Goldberg, Andrew N. , Alzoubaidi, Mohammed , Ashbrook, Liza , Auckley, Dennis , Ayappa, Indu , Bakhtiar, H., Bartley, Bethany L. , Billings, Martha E. , Boon, Maurits , Bosschieter, Pien F. N. , Braverman, Itzhak , Brodie, Kara D. , Caesar, Ray, Cahali, Michel Burihan, Cai, Yi , Cao, Michelle , Capasso, Robson , Caples, Sean M., Chang, Corissa P. , Chang, Katherine W. , Chaudhary, Nilika, Cheong, Crystal , Chowdhuri, Susmita , Cistulli, Peter A. , Claman, David M., Collen, Jacob , Coughlin, Kevin , Creamer, Jennifer , Davis, Eric M. , Dupuy-McCauley, Kara , Durr, Megan L. , Dutt, Mohan, Ali, Mazen El, Elkassabany, Nabil , Epstein, Lawrence J., Fiala, Justin A. , Freedman, Neil, Gill, Kirat, Gillespie, M. Boyd , Golisch, Lea, Gooneratne, Nalaka S., Gottlieb, Daniel J. , Green, Katherine K., Gurubhagavatula, Indira , Hayward, Nathan, Hoffmann, Oliver M. G., Holfinger, Steven , Hsia, Jennifer, Huoh, Kevin C. , Inala, Sanjana , Jobanputra, Aesha M. , Johnson, Andrew P. , Junna, Mithri R. , Kado, Jenna T. , Kaffenberger, Thomas M. , Khan, Meena , Kirsch, Douglas B. , Kominsky, Alan, Kryger, Meir H. , Kushida, Clete A. , Kuzniar, Thomas J., Lim, Diane C , Liu, Stanley Yung‐Chuan , MacKay, Stuart G. , Maurer, Joachim T. , May, Anna M. , Mitchell, Ron B. , Mullins, Anna , Nada, Eman , Naik, Sreelatha , Nokes, Brandon , Olson, Michael D. , Pang, Edward B. , Pang, Kenny P. , Perck, Eli Van de , Piccirillo, Jay F. , Pien, Grace W. , Plawecki, Andrea , Quigg, Mark , Ravesloot, Madeline J. L. , Redline, Susan , Rotenberg, Brian , Ryden, Armand, Sarmiento, Kathleen , Sbeih, Firas , Schell, Amy E., Schotland, Helena , Schwab, Richard J. , Seo, Jiyeon , Shah, Neomi , Shelgikar, Anita V., Shochat, Isaac , Soose, Ryan J. , Steele, Toby O. , Stephens, Erika M. , Stepnowsky, Carl , Thaler, Erica R. , Thapa, Sritika, Vries, Nico de, Weaver, Edward M. , Weir, Ian, Wolfe, Lisa F. , Woodson, B. Tucker , Won, Christine , Xu, Josie , Yalamanchi, Pratyusha , Yaremchuk, Kathleen , Yeghiazarians, Yerem, Yu, Jason L. , Zeidler, Michelle , Rosen, Ilene M. , Alt, Jeremiah A , Mohammed, Alzoubaidi , Ashbrook, Liza , Auckley, Dennis , Ayappa, Indu , Bartley, Bethany L , Braverman, Itzhak , Cahali, Michel B , Cai, Yi , Cheong, Crystal S J , Chowdhuri, Susmita , Cistulli, Peter A , Creamer, Jennifer , Dupuy-McCauley, Kara L , Durr, Megan L , Elkassabany, Nabil M , Fiala, Justin A , Gottlieb, Daniel J , Gulati, Arushi , Holfinger, Steven J , Huntley, Colin , Huyett, Phillip , Inala, Sanjana , Ishman, Stacey L , Jobanputra, Aesha M , Kado, Jenna T , Kezirian, Eric J , Kirsch, Douglas B , Kushida, Clete A , Lam, Derek J , Lettieri, Christopher J , Lin, Hsin-Ching , Magalang, Ulysses J , Malhotra, Atul , Mansukhani, Meghna P , Maurer, Joachim T , May, Anna M , Mitchell, Ron B , Mullins, Anna E , Nada, Eman M , Naik, Sreelatha , Nokes, Brandon T , Pack, Allan I , Pien, Grace W , Piper, Amanda J , Ravesloot, Madeline J L , Redline, Susan , Rotenberg, Brian W , Sarmiento, Kathleen F , Schmickl, Christopher N , Shelgikar, Anita Valanju , Shochat, Isaac , Soose, Ryan J , Steele, Toby O , Stephens, Erika , Strohl, Kingman P , Suurna, Maria V , Vanderveken, Olivier M , Yu, Jason L , Rosen, Ilene M , Alt, Jeremiah A. , Barrera, Jose Enrique , Cabrera‐Muffly, Cristina , Chahine, Lana M. , Hoff, Paul T. , Ishman, Stacey L. , Jella, Tarun K. , Kapur, Vishesh K. , Kezirian, Eric J. , Krystal, Andrew D. , Lam, Derek J. , Malhotra, Atul , Mansukhani, Meghna P. , Mokhlesi, Babak , Pack, Allan I , Patil, Susheel P. , Sutherland, Kate

Mayo Clinic

International Forum of Allergy & Rhinology | September 7, 2022 | Volume: 13 | Issue: 7 | Pages: 1061-1482

10.1002/alr.23079 | PMID 36068685 Get It

ABSTRACT Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA) allows for consolidation and determination of the key factors important for clinical management of the adult OSA patient. Toward this goal, an international collaborative of multidisciplinary experts in sleep apnea evaluation and treatment have produced the International Consensus statement on Obstructive Sleep Apnea (ICS:OSA). Methods Using previously defined methodology, focal topics in OSA were assigned as literature review (LR), evidence‐based review (EBR), or evidence‐based review with recommendations (EBR‐R) formats. Each topic incorporated the available and relevant evidence which was summarized and graded on study quality. Each topic and section underwent iterative review and the ICS:OSA was created and reviewed by all authors for consensus. Results The ICS:OSA addresses OSA syndrome definitions, pathophysiology, epidemiology, risk factors for disease, screening methods, diagnostic testing types, multiple treatment modalities, and effects of OSA treatment on multiple OSA‐associated comorbidities. Specific focus on outcomes with positive airway pressure (PAP) and surgical treatments were evaluated. Conclusion This review of the literature consolidates the available knowledge and identifies the limitations of the current evidence on OSA. This effort aims to create a resource for OSA evidence‐based practice and identify future research needs. Knowledge gaps and research opportunities include improving the metrics of OSA disease, determining the optimal OSA screening paradigms, developing strategies for PAP adherence and longitudinal care, enhancing selection of PAP alternatives and surgery, understanding health risk outcomes, and translating evidence into individualized approaches to therapy.
Transcriptomic Analysis of Cirrhosis-Like Hepatocellular Carcinoma Reveals Distinct Molecular Characteristics and Pathologic Staging Implications
Treeck, Benjamin J. Van , Moreira, Roger K. , Mounajjed, Taofic, Ferrell, Linda D., Xue, Yue , Jessen, Erik , Davila, Jaime , Davila, Jaime I , Graham, Rondell P.

Mayo Clinic

American Journal of Clinical Pathology | September 6, 2022 | Volume: 158 | Issue: 6 | Pages: 750-758

10.1093/ajcp/aqac125 | PMID 36197918 Get It

Abstract Objectives Cirrhosis-like hepatocellular carcinoma (CL-HCC) is a rare hepatocellular malignancy characterized by multiple tumor nodules that clinically, radiologically, macroscopically, and microscopically mimic cirrhosis. We aimed to elucidate the molecular biology of CL-HCC and determine tumor nodule clonality. Methods We performed RNA sequencing on formalin-fixed, paraffin-embedded tissue from confirmed CL-HCC cases (n = 6), along with corresponding nonneoplastic hepatic tissue (n = 4) when available. Transcriptomes from our previous work on steatohepatitic hepatocellular carcinoma and The Cancer Genome Atlas (TCGA) were used for comparison purposes. Results Histologically, CL-HCC displayed innumerable nodules and extensive vascular invasion. Intratumoral nodule comparison indicated that the multiple nodules were all clonally related, not independent primaries. The unique histomorphologic appearance corresponded with a distinct transcriptome compared with other HCCs, including fibrolamellar HCC (n = 6), steatohepatitic HCC (n = 8), and conventional HCC in TCGA (n = 424). Tumor-normal gene expression analysis revealed consistent overexpression of several genes involved in degradation of tissue matrix. No recurrent translocations or point mutations were identified. CL-HCC showed a gene expression profile indicative of zone 2 hepatocytes. Conclusions CL-HCC’s distinctive clinicopathologic features correspond to a unique gene expression profile, increased expression of invasive markers, features of zone 2 hepatocytes, and features suggestive of intratumoral nodule monoclonality.
A Clinical Audit of Cardiovascular Risk Factors and Disease in Patients with Rheumatoid Arthritis - SURF-RA
Ikdahl, Eirik , Wibetoe, Grunde , Sexton, Joseph, Crowson, Cynthia S. , Riel, Piet L. C. M. van , Rollefstad, Silvia , Graham, Ian D. , Semb, Anne Grete , Kerola, Anne M , Kitas, George D. , Graham, Ian

Mayo Clinic

Mediterranean Journal of Rheumatology | September 6, 2022 | Volume: 33 | Issue: 2 | Pages: 201

10.31138/mjr.33.2.201 | PMID 36128215 Get It

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, Eli , Bouman, Walter Pierre , Brown, George R. , Vries, A. de , Deutsch, Madeline B. , Ettner, Randi, Fraser, Lin, Goodman, Michael , Green, J., Hancock, Adrienne B. , Johnson, Thomas W. , Karasic, Dan H., Knudson, Gail, Leibowitz, Scott , Meyer‐Bahlburg, Heino F. L. , Monstrey, S., Motmans, Joz , Nahata, Leena , Reisner, Sari L. , Richards, Christina , Schechter, Loren S. , Tangpricha, Vin , Tishelman, Amy C. , Trotsenburg, M.A.A. van , Winter, Sam , Ducheny, Kelly , Adams, Noah S. , Adrián, T. M., Allen, Luke R. , Azul, David , Bagga, Harjit, Başar, Koray , Bathory, D. S., Belinky, Javier, Berg, Dianne , Berli, Jens U. , Bluebond‐Langner, Rachel , Bouman, Mark‐Bram , Bowers, Marci, Brassard, P., Byrne, Jack, Cargill, C. J., Carswell, Jeremi M. , Chang, Sand C. , Chelvakumar, Gayathri, Corneil, Trevor , Dalke, Katharine B. , Cuypere, Griet De , Vries, Elma De , Devor, Aaron , D’Marco, A., Edmiston, E. Kale , Edwards-Leeper, Laura, Ehrbar, Randall D., Ehrensaft, Diane , Eisfeld, Justus, Elaut, Els , Erickson‐Schroth, Laura, Feldman, Jamie , Garcia, Maurice M. , Gijs, Luk , Green, S. E., Hall, B. P., Hardy, Teresa L. D. , Jacobs, Laura A., Klink, Daniel, Kuper, Laura E. , Kvach, Elizabeth, Malouf, Matthew A., Massey, Ren, Mazur, Tom, McLachlan, Chris tine, Mosser, Scott W., Neira, Paula M. , Nygren, Ulrika , Oates, Jennifer , Pagkalos, Georgios, Patton, J., Rachlin, Katherine, Reed, T., Rider, G. Nic , Ristori, Jiska , Robbins-Cherry, Sally, Roberts, Stephanie , Sabir, K., Seal, Leighton , Sehoole, T. J. , Spencer, K., Amand, Colt St. , Strang, John F. , Taylor, G. B., Vala, L. N., Vencill, Jennifer A. , Wesp, Linda , Rider, G. Nic , Tangpricha, Vin , Roberts, Stephanie A , Radix, Asa E. , Nieder, Timo Ole , Capitán, Luis Pérez , Heijer, Martin den , Dhejne, Cecilia , Fisher, Alessandra D. , Irwig, Michael S. , Jacobs, L. A., Janssen, Aron C. , Johnson, Katherine , Kreukels, Baudewijntje P.C. , McLachlan, Christine , Morrison, Shane D. , Obedin‐Maliver, Juno , Phanuphak, Nittaya , Reed, T., Rodriguez-Wallberg, Kenny A , Rosenthal, Stephen M. , Safer, Joshua D. , Scheim, Ayden I. , Steensma, Thomas D. , Tilleman, Kelly , T’Sjoen, Guy , Mello, Norah M. van , Veale, Jaimie F. , Vincent, Ben , West, Michael A. , Arcelus, Jon

Mayo Clinic

International Journal of Transgender Health | September 6, 2022 | Volume: 23 | Issue: sup1 | Pages: S1-S259

10.1080/26895269.2022.2100644 | PMID 36238954 Get It

Vasculogenic gene therapy: No role for revitalization of structural bone allografts
Rezaie, Elisa S., Visser, Noortje J., Berg, Catherine van den, Bishop, Allen T. , van den Berg, Catherine, Bishop, Allen T , Shin, Alexander Y.

Mayo Clinic

Journal of Orthopaedic Research | September 5, 2022 | Volume: 41 | Issue: 5 | Pages: 1014-1021

10.1002/jor.25438 | PMID 36058614 Get It

AbstractSegmental bone defects are often performed with cryopreserved allografts. They provide immediate stability, but risk nonunion, infection and late stress fracture. Improving the rate and extent of bone revitalization may improve results. Angiogenesis from surgically placed arteriovenous (AV) bundles improves bone blood flow and vitality in cryopreserved rat femora, augmented by vasculogenic growth factors. This study tests the same principal in Yucatan mini‐pigs with a tibial diaphyseal defect, combining surgical angiogenesis with angiogenic gene therapy within cryopreserved orthotopically‐placed allografts. Tibial diaphyseal defects were reconstructed with cryopreserved allografts and rigid internal fixation in 16 mini pigs. Half of the cranial tibial AV bundles placed within the allograft medullary canal were transfected with an adeno‐associated virus containing vascular endothelial growth factor (VEGF) and platelet‐derived growth factor (PDGF) genes (AAV9.VEGF.PDGF). Bone remodeling, angiogenesis, and allograft healing were assessed. During the postoperative survival period 5 of 8 transfected animals developed cutaneous benign vascular lesions at sites remote from the operated hindlimb, causing excessive bleeding. Within the allograft, both medullary (p = 0.013) and cortical (p = 0.009) vascular volumes were higher and vessels more mature than nontransfected allografts. Bone turnover (p = 0.013), bone mineralization (p = 0.018), bone healing (p = 0.008) and graft incorporation (p = 0.006) were all significantly higher in the gene therapy group. In a large animal tibial defect model, gene therapy of implanted AV bundles improved revascularization, remodeling and healing of cryopreserved allografts used for limb reconstruction. However, benign vascular lesions causing excessive bleeding developed in 5 out of 8 pigs transfected with AAV containing genes for VEGF and PDGF. This unforeseen complication makes vasculogenic gene therapy unacceptable for clinical use.
Stereotactic Radiosurgery Outcomes in Medically and Surgically Failed or Nonsurgical Candidates with Medically Failed Prolactinomas: A Systematic Review and Meta-Analysis
Yagnik, Karan J. , Erickson, Dana , Laack, Nadia N., Gompel, Jamie J. Van , Van Gompel, Jamie J , Bancos, Irina , Choby, Garret

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | August 31, 2022 | Volume: 84 | Issue: 06 | Pages: 538-547

10.1055/a-1934-9028 | PMID 37854534 Get It

Abstract Objective Prolactinomas are treated with dopamine agonists (DAs) as first-line therapy and transsphenoidal surgery as an alternative approach for medically failed tumors. We sought to summarize the efficacy of stereotactic radiosurgery (SRS) in the medically and surgically failed prolactinomas as well as in nonsurgical candidates with medically failed prolactinomas by systematic review and meta-analysis. Method A literature search was conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guideline. Results A total of 11 articles (total N = 709) met inclusion criteria. Thirty-three percent of patients were able to achieve endocrine remission at a mean follow-up of 54.2 ± 42.2 months with no association between stopping DA and endocrine remission. Sixty-two percent of patients were able to achieve endocrine control with DA therapy and 34% of patients were able to decrease the dose of DA dose when compared with pre-SRS DA dose at the end of the follow-up period. However, 54% of patients required DA at the end of the follow-up to control hyperprolactinemia. Ninety percent of patients were able to achieve radiologic control at the end of the follow-up in comparison to pre-SRS imagings. Furthermore, 26% of patients newly developed hypopituitarism (one or more pituitary hormones) post-SRS throughout the follow-up period. Conclusion This systematic review and meta-analysis demonstrates SRS as an effective adjunct therapy in medically failed nonsurgical candidates or surgically and medically recalcitrant prolactinomas with a 33% chance of achieving endocrine remission, 62% of patients achieved hormonal control with DA and GKRS (gamma knife radio-surgery), with a 34% chance of decreasing DA dose and 90% chance of achieving radiologic control.
Ovarian Signet-ring Stromal Tumor
Tchrakian, Naïri , Oliva, Esther , Rivera-Polo, Barbara, Nucci, Marisa R. , Sah, Shatrughan Prasad , Schoolmeester, J. Kenneth , Griend, Rachael van der , Young, Robert H. , McCluggage, W. Glenn , Chong, Anne‐Sophie , Bennett, Jennifer A. , Foulkes, William D. , Clarke, Blaise

Mayo Clinic

American Journal of Surgical Pathology | August 30, 2022 | Volume: 46 | Issue: 12 | Pages: 1599-1610

10.1097/pas.0000000000001954 | PMID 36040033 Get It

Signet-ring stromal tumor (SRST) is a rare ovarian stromal neoplasm characterized by a population of bland signet-ring cells, devoid of mucin or lipid, in a generally cellular fibromatous stroma. Previous reports have described heterogenous immunohistochemical and molecular genetic findings, including occasional nuclear β-catenin expression and/or CTNNB1 mutations. We report 10 ovarian stromal neoplasms originally diagnosed as SRST. All but 1 tumor underwent detailed immunohistochemical analysis (including β-catenin) and 5 of 10 had CTNNB1 mutation analysis performed. All tumors contained a population of morphologically bland signet-ring cells that ranged from 15% to 95% of the neoplasm, characterized by a single large empty intracytoplasmic vacuole, mostly with nuclear indentation. Six of the 10 tumors contained cellular fibroma-like areas, comprising from 10% to 85% of the neoplasm. Three of the 10 tumors were reclassified as microcystic stromal tumor with signet-ring cells on the basis of the microcyst formation and hyalinized stroma, beta-catenin and cyclin D1 nuclear expression and/or CTNNB1 mutation, CD10 staining and largely absent expression of inhibin and calretinin. In the remaining 7 tumors, the diagnosis of SRST remained, constituting the largest series of SRST reported in the literature to date. The results of our study suggest that a subset of tumors diagnosed as ovarian SRST, especially those which show β-catenin nuclear positivity and/or CTNNB1 mutation, likely represent microcystic stromal tumor with variant morphology. We also suggest that at least a subset of SRSTs without evidence of Wnt/β-catenin pathway abnormalities may be related to ovarian fibromas. We discuss the differential diagnosis of ovarian neoplasms containing signet-ring cells.